Contraception for Transgender and Gender Nonbinary Individuals: A 2024 Update - SCS34

Sunday, May 19, 2024

12:45 PM - 1:45 PM PDT

Location: 25

CME Credits 1

Sub Topic: Contraception

Lauren Abern, MD, FACOG (she/her/hers)

Assistant professor of gynecology and obstetrics
Emory University
Emory University
Atlanta, FL, United States
Karla Maguire, MD, FACOG (she/her/hers)

Associate Professor
Dell Medical School at the University of Texas Austin
Dell Medical School - University of Texas at Austin
Austin, TX, United States
Miles Harris, FNP

Director of Gender-Affirming Care, Health Sciences Assistant Clinical Professor
UC Davis Health
UC Davis
Sacramento, CA, United States

Session Description
Some transgender and gender nonbinary individuals taking testosterone are unaware that they may require contraception for pregnancy prevention. These patients also often receive inadequate education in regards to pregnancy prevention and face numerous barriers to accessing contraception and abortion services. In the past few years, more research has been published on contraceptive use and abortion in this population. The goal of this session is to review the most recent data with the goal of enabling healthcare providers to feel more confident in assisting a transgender and nonbinary patient with their reproductive health needs.

Disclosure(s):

Lauren Abern, MD: No financial relationships to disclose

Karla Maguire, MD: No financial relationships to disclose

Miles Harris, FNP: Gilead Sciences: Speaker/Honoraria (Ongoing)